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BRIEF COMMUNICATION
FIRST ISOLATION OF DENGUE 4 IN THE STATE OF SÃO PAULO, BRAZIL, 2011
Iray Maria ROCCO(1), Vivian Regina SILVEIRA(1), Adriana Yurika MAEDA(1), Sarai Joaquim dos Santos SILVA(1),  
Carine SPENASSATTO(1), Ivani BISORDI(1) & Akemi SUZUKI(1)
SUMMARY
We report the first isolation of Dengue virus 4 (DENV-4) in the state of São Paulo, from two patients - one living in São José 
do Rio Preto and the other one in Paulo de Faria, both cities located in the Northwest region of the state. The virus isolations were 
accomplished in the clone C6/36 Aedes albopictus cell line, followed by indirect immunofluorescence assays, performed with type-
specific monoclonal antibodies that showed positive reactions for DENV-4. The results were confirmed by Nested RT-PCR and Real-
Time RT-PCR assays. The introduction of DENV-4 in a country that already has to deal with the transmission of three other serotypes 
increases the possibility of the occurrence of more severe cases of the disease. The importance of early detection of dengue cases, 
before the virus spreads and major outbreaks occur, should be emphasized. 
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Dengue is currently a major public-health problem, having 
become the most significant vector-borne viral disease worldwide1. 
Approximately 2 billion people live in risk areas, consisting mostly of 
tropical and subtropical developing countries, which means that 2/5 
of world population is at risk of contracting dengue6. Dengue, in the 
Americas, has shown an upward trend, with more than thirty countries 
reporting cases of the disease15. 
Historically, references based on clinical signs for the presence of 
Dengue virus (DENV) in the 20th century in Brazil, date from 1916 in 
the state of São Paulo7 and 1923 in the state of Rio de Janeiro (Niteroi)13. 
However, there is no laboratory diagnosis documentation. The virus 
reemerged in the North of Brazil in 1981, when an epidemic caused by 
DENV-1 and DENV-4 was registered in Boa Vista (RO)12. After that, 
a major outbreak caused by DENV-1 occurred in Rio de Janeiro in 
19869. The serotypes 2 and 3 were also introduced into the country in 
the following years through Rio de Janeiro, spreading to the other states 
where the vector Aedes aegypti has been present since its reintroduction 
in the late 70’s9,10.
Dengue transmission, with clinical and laboratory diagnosis, began 
to be reported in the state of São Paulo in March 198714. In the summer 
of 1990/91 an epidemic of major proportions caused by DENV-1 started 
in Ribeirão Preto, and quickly spread to neighboring counties and other 
regions2,14. In 1997, a new serotype, DENV-2 was introduced and in 
2002 the first autochthonous case of DENV-3 was reported16. Epidemics 
have occurred yearly in different regions of the state with transmission 
throughout the year, showing that the disease has become endemic in 
several counties2.
In August 2010, the first cases of DENV-4 were registered in Brazil, 
in Boa Vista (RO)17. Subsequently, the virus was detected in the North 
(states of Amazonas and Pará) and in the Northeast (states of Bahia, 
Pernambuco and Piauí)8. In the Southeast, the first episode of the disease 
occurred in the state of Rio de Janeiro in 201111. 
In the present study, we report the first isolations of DENV-4 in the 
state of São Paulo, from two patients - one living in São José do Rio Preto 
and the other one in Paulo de Faria, both located in the Northwest region 
of the state. The onset of the symptoms occurred on 27th February 2011 
for the patient from São José do Rio Preto (SPH 317947) and 4th March 
2011 for the patient from Paulo de Faria (SPH 319325). The symptoms 
shown by the patients were fever, headache and myalgia, compatible 
with the classification of Dengue Fever. The evolution of the disease 
was satisfactory, with complete recovery. 
Virus isolations were accomplished in clone C6/36 Aedes albopictus 
cell line, inoculated with serum samples collected from both patients on 
the day one after the onset of symptoms. Indirect immunofluorescence 
assays, performed with type-specific monoclonal antibodies3, showed 
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a positive reaction for DENV-4. Negative and positive controls were 
used in the tests.
The results were confirmed by conventional Nested Reverse 
Transcriptase Polymerase Chain Reaction (Nested RT-PCR) and 
Real-Time RT-PCR assays. Briefly, viral RNA was extracted either 
from the patient’s serum or the supernatant of the C6/36 infected cells 
by using QIAamp Viral RNA Mini kit (QIAGEN, Valencia, CA, USA). 
Nested RT-PCR was performed employing the protocol described by 
LANCIOTTI et al., 19926; the Real-Time RT-PCR in a fourplex format 
was accomplished using the protocol described by JOHNSON et al., 
20055 protocol, in a LightCyclerR 480 II System (Roche Applied Science). 
The crossing point cycle threshold values (Cp) for this assay are shown 
in Table 1. The samples were determinated to be positives if the Cp value 
was ≤ 36.
. 
Agarose gel analysis of the DNA product
 
from dengue viruses 
are shown in Fig. 1. Nested RT-PCR products were purified and directly 
sequenced using Big Dye v.3.3 terminator chemistry. Sequences were 
determined using the Applied Biosystems 3130XL DNA sequencer. The 
nucleotide sequences of capsid-prM junction for the DENV-4 serotype, 
generated for this study, are deposited in GenBank under accession 
numbers JN092554 (SPH 317947) and JN092556 (SPH 319325).
São José do Rio Preto is situated 454 km from the capital of the 
state and has a population of 408,435 inhabitants4. The city is a great 
industrial, cultural and service center in the region, being cut by two 
major and important highways4. 
Paulo de Faria is a small town of 8,589 inhabitants4, 540 km away 
from the capital of the state. It is situated on the banks of the River Grande 
(Água Vermelha dam) on the border of the State of Minas Gerais4. As this 
area is surrounded by rivers, it attracts many people interested in fishing. 
For all these reasons the presence of DENV-4 in this region is a 
cause for concern since there is a massive number of people and also 
because several epidemics of serotypes 1, 2 and 3 have already occurred. 
In addition, as DENV-4 has not circulated in Brazil for almost 30 years, 
the majority of the population is vulnerable to it. It is essential to use 
rapid and sensitive laboratory diagnostic techniques to ensure early 
detection of cases.
The introduction of DENV-4 into a country that already had to deal 
with the transmission of the other three serotypes increases the possibility 
of occurrence of more severe cases of the disease. The importance of early 
detection of dengue cases, before the virus spreads and major outbreaks 
occur, should be emphasized. 
RESUMO
Primeiro isolamento de Dengue 4 no Estado de São Paulo, Brasil, 
2011
Relatamos o primeiro isolamento do vírus Dengue 4 (DENV-4) no 
Estado de São Paulo, de dois pacientes residentes em São José do Rio 
Preto e Paulo de Faria, ambos municípios localizados na região Noroeste 
do Estado. O isolamento do vírus foi realizado em clone C6/36, linhagem 
de células de Aedes albopictus seguido por imunofluorescência indireta, 
realizada com anticorpos monoclonais tipo específicos, que apresentou 
reação positiva para DENV-4. Os resultados foram confirmados por testes 
de Nested RT-PCR e RT-PCR em Tempo Real. A introdução do DENV-
4 no país, com uma população suscetível a esse vírus e que já convive 
com a transmissão de outros três sorotipos, aumenta a possibilidade 
da ocorrência de casos mais graves da doença. Deve ser enfatizada a 
importância da detecção precoce de casos de dengue, antes que ocorra 
a propagação do vírus e que surtos importantes aconteçam. 
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Analysis of samples from two patients with suspected DENV infection


















* bp: base pair. **Avg Cp: Average of crossing point cycle threshold, automatically calculated by the LightCycler 480 II software (Roche Applied Science). 
Fig. 1 - Agarose gel analysis of Nested RT-PCR products from Dengue virus. Lane 1 and 
10: 1 kb Plus ladder (Invitrogen); Lane 2: sample patient - SPH 319325 (392 bp); Lane 3: 
sample patient - SPH 317947 (392 bp); Lane 4 and 5: negative control; Lane 6: positive 
control DENV-1 (482 bp); Lane 7: positive control DENV-2 (119 bp); Lane 8: positive control 
DENV-3 (290 bp); Lane 9: positive control DENV-4 (392 bp).
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